Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Published:23rd Aug, 2021 at 3:39 PM

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

SCROLL FOR NEXT

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Also Read

6 women among 15 lawyers designated by J&K High Court as Senior Advocates

Ujjwal Nikam to appear as special prosecutor in Lohagad Fort murder case

National Judicial Reforms Commission: A proposal we ignore at our peril [Part I]

ILS wanted to collect ₹1.12 crore for moot court against actual spend of ₹1.98 lakh: SPPU to Bombay HC

Justice Manoj Jain to replace Justice Swarana Kanta Sharma for MP/MLA cases as Delhi HC roster changes